RYTM
Rhythm Pharmaceuticals, Inc. · Healthcare
EVP, Head of International Yann Mazabraud sold $6.6M of Rhythm Pharmaceuticals, Inc.
Sold$6,620,575
$116.15Price
57,000Shares
−51%Stake
What RYTM did after the filing
- The stock from Tue, Aug 18 open, $115.25
- −17.4%
- S&P 500, same days
- −0.8%
Measured over 30 trading days, to the Sep 30 close.
Traded Wed, Aug 12. Filed Fri, Aug 14, 7:01 PM ET, after the close. Returns use the Aug 18 open and the Sep 30 close. Not investment advice.